bpc 157 for back BPC-157 – Research Peptide How BPC-157 Helped Me Get

Protocol approach 1: immune rebalancing (thymosin alpha-1 plus KPV) Goal: Restore regulatory immune function while reducing inflammatory signaling Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week (promotes Treg expansion, modulates dendritic cells) KPV: 200-500 mcg daily, orally or subcutaneously (inhibits NF-kB, reduces TNF-alpha and IL-6) Rationale: Thymosin alpha-1 works at the cellular level to rebuild the regulatory arm of the immune system, while KPV addresses the inflammatory signaling that drives acute symptoms

Then 8mg

These effects typically resolve within the first week

Sleep disturbance, stress, inflammatory states, nutritional deficiencies, and reduced activity may not be the primary cause, but they can help maintain pain once PHN has become chronic

Monitoring & Support Regular check-ins keep dosing safe and comfortable